Get the Stockscreener App
72.17
1.06%
0.76
After Hours:
72.17
Hologic Inc Stock (HOLX) Latest News
Hologic Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Hologic, Inc. (NASDAQ:HOLX) Holdings Decreased by Swedbank AB - MarketBeat
Digital X-ray Devices Market Deep Research Report with Forecast - openPR
Fluoroscopy Devices Market Deep Research Report with Forecast by 2032 | Hologic Inc., Siemens Healthcare GmbH - openPR
Mount Yale Investment Advisors LLC Has $373,000 Stock Holdings in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Hologic (HOLX) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
Breast Health Performance Likely to Aid Hologic's Q1 Earnings - Yahoo Finance
Stephens Adjusts Hologic Price Target to $84 From $90, Maintains Overweight Rating - Marketscreener.com
Hologic (HOLX) Expected to Announce Quarterly Earnings on Wednesday - Defense World
Hologic's Q1 Earnings Coming Up: How to Play the Stock? - MSN
Hologic (HOLX) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance
Hologic Inc. stock outperforms competitors despite losses on the day - MarketWatch
Mammography Market To Expand US$ 6,922.7 Million By 2033 | GE Healthcare, Analogic Corp, Hologic Inc.Siemens - EIN News
Fifth Third Bancorp Sells 9,780 Shares of Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Hologic digital cytology system wins FDA approval - MSN
Empirical Financial Services LLC d.b.a. Empirical Wealth Management Raises Position in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Portable Medical Devices Market: Growth Drivers - openPR
Olstein Capital Management L.P. Acquires 5,000 Shares of Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Hologic, Inc. (NASDAQ:HOLX) Position Increased by Nisa Investment Advisors LLC - MarketBeat
Crossmark Global Holdings Inc. Acquires 14,487 Shares of Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Aesthetic Medicine Market Growth in Future Scope 2025-2032 | - openPR
Bone Cancer Diagnosis Market is Expected to Grow at a CAGR of 4.6% - openPR
How Is The Market Feeling About Hologic? - Benzinga
Q3 Earnings Estimate for Hologic Issued By Leerink Partnrs - MarketBeat
Hologic Faces FDA Warning Over Biozorb Markers - Zenopa
Why Hologic (HOLX) Outpaced the Stock Market Today - MSN
Hologic Inc. stock outperforms competitors on strong trading day - MarketWatch
BioZorb Lawuit LawyerBreast Biopsy Marker RecallJanuary 2025 Update - Levin Papantonio
AI can have an incredible impact on healthcare: Hologic CEO - Fox Business
Leerink Partnrs Has Bearish Outlook for Hologic Q2 Earnings - MarketBeat
Wake-up Call: Shocking Decline In Global Women’s Cancer Testing - BERNAMA
Wake-up call: Decline in global women’s cancer testing - The Star Online
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know - MSN
New Report Reveals Alarming Decline in Women’s Cancer Testing Worldwide - ANTARA English
Assenagon Asset Management S.A. Reduces Stock Holdings in Hologic, Inc. (NASDAQ:HOLX) - Defense World
Global Women's Health Crisis: Cancer Testing Plummets to 10% as Food Insecurity Surges, Hologic Reports - StockTitan
John Chevedden Submits a Shareholder Proposal to Hologic -January 16, 2025 at 04:16 pm EST - Marketscreener.com
Hologic, Inc. (NASDAQ:HOLX) Short Interest Update - MarketBeat
Hologic, Inc. (NASDAQ:HOLX) Shares Purchased by LaFleur & Godfrey LLC - MarketBeat
Cancer Biopsy Market Size is Expected to Reach USD 60.92 Billion by 2033, Growing at a CAGR of 7.81%: Straits Research - GlobeNewswire Inc.
Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock - Yahoo Finance
Avanza Fonder AB Makes New $1.86 Million Investment in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
The 'coolest thing made in Delaware' may save more than 20,000 lives a year - MSN
Boston Common Asset Management LLC Has $16.41 Million Holdings in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
FDA warns Hologic to do more to prevent harm from component in recalled implant markers - Plastics News
Hologic: Reasonably, But Not Compellingly Valued (NASDAQ:HOLX) - Seeking Alpha
Is Trending Stock Hologic, Inc. (HOLX) a Buy Now? - MSN
Earnings Preview: What To Expect From Hologic's Report - MSN
BioZorb Lawsuit - Lawsuit Information Center Blog
Breast Cancer Patient Advances Hologic Suit Over BioZorb Device - Bloomberg Law
Hologic receives FDA warning letter over Biozorb implantable markers - MedTech Dive
Biopsy Devices Market Global Report and Company Analysis - GlobeNewswire
Biopsy Devices Market Global Report and Company Analysis 2025-2033 Featuring Cardinal Health, Hologic, Danaher, Becton, Dickinson and Co, Boston Scientific, Medtronic, Olympus, and CONMED - Yahoo Finance
Hologic, Inc. (NASDAQ:HOLX) Receives $88.92 Consensus Target Price from Analysts - MarketBeat
FDA threatens Hologic with punishment for reported errors in making troubled breast device - Radiology Business
Hologic Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Marlborough device maker receives FDA warning regarding implantable devices - The Business Journals
Hologic Hits New 52-Week Low: How to Play the Stock Now? - MSN
0.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):